Oct 5, 2020

Gene therapy for hemophilia remains a very active area of research, although it may take longer than expected. Moderated by NHF President and CEO Leonard A. Valentino, MD, this webinar will feature Glenn Pierce, MD, PhD; Steve Pipe, MD; and Margaret Ragni, MD. They will discuss the current status of gene therapies in the pipeline and other novel therapies.

Stay connected with us! Subscribe to receive the latest news on treatments, clinical trials, advocacy issues, and NHF events.